0 Commentaires
0 Parts
1879 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
- Connectez-vous pour aimer, partager et commenter!
- Bioprocess Validation Market is Estimated To Witness High Growth Owing To Increasing Demand Of Monoclonal Antibodies for Chronic DiseasesThe Bioprocess Validation Market is estimated to be valued at US$ 356.8 Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bioprocess validation includes confirming that any procedure, process, equipment, material, activity or system leads to the expected results. It...0 Commentaires 0 Parts 1816 Vue 0 Aperçu
- Bioreactors Market is poised to Witness High Growth due to Rising Demand for Monoclonal AntibodiesThe bioreactors market revolves around products utilized for carrying out reactions that involve biological components such as microorganisms, enzymes, or cells. Bioreactors find widespread usage in biotechnology and pharmaceutical industries for manufacturing biotherapeutics, vaccines, and antibiotics. They provide controlled environmental conditions essential for cell and tissue growth, which...0 Commentaires 0 Parts 279 Vue 0 Aperçu
- Cancer Monoclonal Antibodies Market Global Trends Forecast 2022-28The global cancer monoclonal antibodies market size was valued at USD 47.2 billion in 2021 and is poised to grow at a significant CAGR of 11.8% during the forecast period 2022-28. Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on “Cancer Monoclonal Antibodies Market: By...0 Commentaires 0 Parts 2125 Vue 0 Aperçu
- Cancer Monoclonal Antibodies Market is Witnessed to Hit The Value Of USD 231.4 Billion By 2033As per the current market research conducted by the CMI Team, the global Cancer Monoclonal Antibodies Market size is expected to record a CAGR of 8.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 113.8 Billion. By 2033, the valuation is anticipated to reach USD 231.4 Billion. Cancer Monoclonal Antibodies Market: Growth...0 Commentaires 0 Parts 41 Vue 0 Aperçu
- Cancer Monoclonal Antibodies Market Size, Analysis and Forecast 2031The Cancer Monoclonal Antibodies Market in 2023 is US$ 89.23 billion, and is expected to reach US$ 354.52 billion by 2031 at a CAGR of 18.80%. FutureWise Research published a report that analyzes Cancer Monoclonal Antibodies Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure....0 Commentaires 0 Parts 1435 Vue 0 Aperçu
- Cancer Monoclonal Antibodies Market Size, Share, Emerging Trends and Overview 2030The report " Cancer Monoclonal Antibodies Market by Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain cancer, Colorectal Cancer, Other), by Type of Antibody (Murine Antibodies, Humanized Antibodies, Chimeric Antibodies), by Conjugation (Immunocytokines, Immunoliposome, Radioimmunotherapy, Antibody Directed Enzyme Prodrug Therapy (ADEPT)), by Distribution Channel (Hospital...0 Commentaires 0 Parts 808 Vue 0 Aperçu
- Complete Monoclonal Antibodies Market Analysis & Forecast 2021-2028Growth Market Reports has included a latest report on the Global Monoclonal Antibodies Market into its archive of market research studies. The report is an amalgamation of detailed market overview based on the segmentations, applications, trends and opportunities, mergers and acquisitions, drivers, and restraints. The report showcases the current and forthcoming technical and financial details...0 Commentaires 0 Parts 1708 Vue 0 Aperçu
- Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay DevelopmentCreative Diagnostics announces the availability of its highly specific Anti-Adenovirus Monoclonal Antibody. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its highly specific Anti-Adenovirus Monoclonal Antibody. This research tool offers exceptional accuracy and sensitivity for the detection of...0 Commentaires 0 Parts 138 Vue 0 Aperçu
- Demand Discovery: Monoclonal Antibodies Market Research Techniques for Predicting Revenue StreamsThe global monoclonal antibodies market size was USD 204.42 billion in 2022 and is expected to register a revenue CAGR of 10.8% during the forecast period. Rising adoption in personalized medicine and precision therapies, expanding regulatory approvals of monoclonal antibodies by regulatory agencies across the globe, and increasing technological advancements in biotechnology and immunology are...0 Commentaires 0 Parts 1908 Vue 0 Aperçu
- Custom Antibody Market Promoting Growth, Dynamics, Efficiency Forecast to 2029The new study published by Data Library Research, titled, “Custom Antibody Market by type, application, end user, and region: industry forecast and market potential analysis, 2023-2029,” the global Custom Antibody market is rising at substantial rate and is projected to maintain its progress during the prediction period. The study elaborates growth rate of the...0 Commentaires 0 Parts 4382 Vue 0 Aperçu
- Cancer Biologics: The Forthcoming of Cancer TreatmentCancer Biologics: The Forthcoming of Cancer Treatment What are Cancer Biologics?Biologics, also known as biological drugs, are medicines produced from living organisms using biotechnology. In oncology, biologics are designed to target specific molecules involved in cancer growth and progression. Unlike traditional chemotherapy that targets all rapidly dividing cells, biologics work with...0 Commentaires 0 Parts 1322 Vue 0 Aperçu
- Cancer Immunotherapy Market is Slated to Witness Tremendous Growth in Coming Years: 2023-2028The Cancer Immunotherapy Market research study offers stakeholders in-depth insights into the dynamics of the market and its different fragmentations. This study provides stakeholders with comprehensive industry elements through detailed-driven information that is based on reliable, impartial, and accurate data. The study offers in-depth qualitative and quantitative insights on market...0 Commentaires 0 Parts 10186 Vue 0 Aperçu
- CD38 and Multiple Myeloma: Unleashing the Potential of Targeted TherapiesUnleashing the Potential: CD38 Directed Therapies Revolutionize Multiple Myeloma Treatment Introduction Multiple Myeloma is a complex and incurable hematologic malignancy characterized by the proliferation of abnormal plasma cells in the bone marrow. Despite advances in treatment, the disease remains challenging due to its heterogeneous nature and the development of drug resistance. Recent...0 Commentaires 0 Parts 616 Vue 0 Aperçu
- Europe Monoclonal Antibodies Market Consumer TrendsMarket Introduction & Size Analysis: The global monoclonal antibodies market is projected to reach approximately US$729.4 billion by the end of 2031, up from US$276.9 billion in 2024, representing a robust CAGR of 12.4% from 2024 to 2031. This growth underscores the increasing importance of monoclonal antibodies within the biopharmaceutical sector. The Monoclonal antibodies (mAbs) market...0 Commentaires 0 Parts 507 Vue 0 Aperçu
Plus de résultats